Is Bachem AG FDA approved?

Bachem AG holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Bachem AG's drugs manufactured?

The FDA register lists Bubendorf. Registered operations: analytical testing, active ingredient (API) manufacture.

What drugs does Bachem AG make?

23 products are listed under Bachem AG in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Bachem AG

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 23
Live patents: 0
Countries: 1
Base: Switzerland

Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Bachem AG	Hauptstrasse 144, Bubendorf, 4416, Switzerland (CHE)	Analytical testing, Active ingredient (API) manufacture	1000153019482220311

Catalogue

Drug listings by form and route

23 active NDC listings: 23 bulk ingredient. By marketing category: BULK INGREDIENT 23.

Dosage form	NDCs
powder	23

Route	NDCs

Labeller name on the listing	NDCs
bachem ag	23

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Aprotinin	powder	55463-0031BULK INGREDIENT
-	Bivalirudin	powder	55463-0029BULK INGREDIENT
-	Buserelin	powder	55463-0024BULK INGREDIENT
-	DASIGLUCAGON HYDROCHLORIDE	powder	55463-0037BULK INGREDIENT
-	ETELCALCETIDE	powder	55463-0030BULK INGREDIENT
-	Glucagon	powder	55463-0009BULK INGREDIENT
-	Gonadorelin	powder	55463-0016BULK INGREDIENT
-	Goserelin	powder	55463-0005BULK INGREDIENT
-	Histrelin Acetate	powder	55463-0008BULK INGREDIENT
-	Icatibant Acetate	powder	55463-0033BULK INGREDIENT
-	Leuprorelin	powder	55463-0002BULK INGREDIENT
-	Nitisinone	powder	55463-0034BULK INGREDIENT
-	Octreotide Acetate	powder	55463-0035BULK INGREDIENT
-	Octreotide Hydrochloride	powder	55463-0038BULK INGREDIENT
-	PENTETREOTIDE	powder	55463-0032BULK INGREDIENT
-	Palopegteriparatide	powder	55463-0039BULK INGREDIENT
-	Pegcetacoplan	powder	55463-0036BULK INGREDIENT
-	Rusfertide	powder	55463-0041BULK INGREDIENT
-	Semaglutide	powder	55463-0040BULK INGREDIENT
-	Sincalide	powder	55463-0004BULK INGREDIENT
-	Tetracosactide	powder	55463-0015BULK INGREDIENT
-	Triptorelin Acetate	powder	55463-0007BULK INGREDIENT
-	Triptorelin Pamoate	powder	55463-0006BULK INGREDIENT

Neighbours

Registered in the same town

CARBOGEN AMCIS AGBubendorf, CHE

Compare

Comparable companies in Switzerland

Herbamed AG1 site · 173 NDC
Avyxa GmbH1 site · 29 NDC
Vifor (International) AG1 site · 22 NDC
DOTTIKON EXCLUSIVE SYNTHESIS AG1 site · 16 NDC
HAS Healthcare Advanced Synthesis SA1 site · 11 NDC
Cerbios-Pharma SA1 site · 9 NDC
SINTETICA S.A.1 site · 9 NDC
Bachem SA, Succursale de Vionnaz1 site · 5 NDC
MICRO-MACINAZIONE SA1 site · 5 NDC
Debiopharm Research & Manufacturing SA1 site · 4 NDC

Enquiry

Common questions

Is Bachem AG FDA approved?: Bachem AG holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Bachem AG's drugs manufactured?: The FDA register lists Bubendorf. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Bachem AG make?: 23 products are listed under Bachem AG in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.